Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects

Background We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of epidemiology Jg. 40; H. 4; S. 419 - 425
Hauptverfasser: Shi, Joy, Løberg, Magnus, Kalager, Mette, Wieszczy, Paulina, Pilonis, Nastazja D., Adami, Hans-Olov, Kaminski, Michal F., Bretthauer, Michael, Hernán, Miguel A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Dordrecht Springer Netherlands 01.04.2025
Springer Nature B.V
Schlagworte:
Aged
Cancer
Cardiology
Clinical outcomes
Clinical trials
Colonoscopy
Colonoscopy - statistics & numerical data
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - mortality
Colorectal Neoplasms - prevention & control
Confidence intervals
Disease prevention
Early Detection of Cancer - methods
Epidemiology
Estimates
Female
Health risks
Humans
Incidence
Infectious Diseases
Male
Mass Screening - methods
Medical screening
Medicine
Medicine & Public Health
Middle Aged
Mortality
Oncology
Public Health
Risk
Risk Factors
Screening
Instrumental variable
Screening
Per-protocol
Colonoscopy
Colorectal cancer
ISSN:0393-2990, 1573-7284, 1573-7284
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.
AbstractList We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.
We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.BACKGROUNDWe recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.
Background We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.
BackgroundWe recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.
Author Adami, Hans-Olov
Pilonis, Nastazja D.
Kalager, Mette
Wieszczy, Paulina
Løberg, Magnus
Hernán, Miguel A.
Kaminski, Michal F.
Bretthauer, Michael
Shi, Joy
Author_xml – sequence: 1
  givenname: Joy
  orcidid: 0000-0002-4234-7999
  surname: Shi
  fullname: Shi, Joy
  email: joyshi@hsph.harvard.edu
  organization: CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health
– sequence: 2
  givenname: Magnus
  surname: Løberg
  fullname: Løberg, Magnus
  organization: Clinical Effectiveness Research Group, University of Oslo, Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital
– sequence: 3
  givenname: Mette
  surname: Kalager
  fullname: Kalager, Mette
  organization: Clinical Effectiveness Research Group, University of Oslo, Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital
– sequence: 4
  givenname: Paulina
  surname: Wieszczy
  fullname: Wieszczy, Paulina
  organization: Clinical Effectiveness Research Group, University of Oslo, Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Medical Center for Postgraduate Education
– sequence: 5
  givenname: Nastazja D.
  surname: Pilonis
  fullname: Pilonis, Nastazja D.
  organization: Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Medical Center for Postgraduate Education
– sequence: 6
  givenname: Hans-Olov
  surname: Adami
  fullname: Adami, Hans-Olov
  organization: Clinical Effectiveness Research Group, University of Oslo, Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
– sequence: 7
  givenname: Michal F.
  surname: Kaminski
  fullname: Kaminski, Michal F.
  organization: Clinical Effectiveness Research Group, University of Oslo, Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Medical Center for Postgraduate Education
– sequence: 8
  givenname: Michael
  surname: Bretthauer
  fullname: Bretthauer, Michael
  organization: Clinical Effectiveness Research Group, University of Oslo, Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Institute of Clinical Medicine, University of Tromsø
– sequence: 9
  givenname: Miguel A.
  surname: Hernán
  fullname: Hernán, Miguel A.
  organization: CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Department of Biostatistics, Harvard T.H. Chan School of Public Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40278966$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:161554427$$DView record from Swedish Publication Index (Karolinska Institutet)
BookMark eNp9kUtv1DAUhS1URKeFP8ACWWLDJuX6kcRmh6rykCqxgbXlODfFbcYebKej_gT-Ne7MtEhddOWHvnN8rs8JOQoxICFvGZwxgP5jZtC1sgHeNsA46Gb7gqxY24um50oekRUILRquNRyTk5yvAUCBbl-RYwm8V7rrVuTvxTShKzRO1MU5hphd3NzR7BJi8OGKxkCTzzf5gUiVtjN1NjhM1IaRJpxtwZGOaMvvT9SHXNKyxnCP3drk7TAjxVz82hZf7arRBlOzSbHE6khxlyC_Ji8nO2d8c1hPya8vFz_PvzWXP75-P_982TjJutLwjiOXQlkx2NHJoc4L1lo5qGkApXqpgQnRaTWyQWDbKyZ6wXqn65mPWopTcrb3zVvcLIPZpBos3ZlovTlc3dQdGgZctgKq4MNeUBP_WeogZu2zw3m2AeOSjWBadm3HuKro-yfodVxSqOMYwVnXKhCMVerdgVqGNY6PCR5aqQDfAy7FnBNOjwgDc1-92VdvavVmV73ZVpF6InK-7H68JOvn56Xi8CX1nXCF6X_sZ1T_AKWyxMI
CitedBy_id crossref_primary_10_1007_s10654_025_01269_y
Cites_doi 10.1056/NEJMoa1114635
10.1056/NEJMsm1605385
10.1097/EDE.0000000000000469
10.1002/sim.8471
10.1111/rssb.12262
10.1056/NEJMoa2208375
10.1055/s-0032-1306895
10.1001/jama.2014.8266
10.1093/jnci/djr284
10.1001/jamainternmed.2016.0960
10.1056/NEJMc2215192
10.1097/01.ede.0000222409.00878.37
10.1186/s13063-015-1056-8
10.1016/S0140-6736(10)60551-X
ContentType Journal Article
Contributor Emilsson, Louise
Contributor_xml – sequence: 1
  givenname: Louise
  surname: Emilsson
  fullname: Emilsson, Louise
Copyright Springer Nature B.V. 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. Springer Nature B.V.
Copyright Springer Nature B.V. Apr 2025
Copyright_xml – notice: Springer Nature B.V. 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. Springer Nature B.V.
– notice: Copyright Springer Nature B.V. Apr 2025
CorporateAuthor The NordICC Study Group
CorporateAuthor_xml – name: The NordICC Study Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7TK
7TS
7U7
7U9
C1K
H94
K9.
7X8
ADTPV
AOWAS
DOI 10.1007/s10654-025-01209-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SwePub
SwePub Articles
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Neurosciences Abstracts
Physical Education Index
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1573-7284
EndPage 425
ExternalDocumentID oai_swepub_ki_se_1024530
40278966
10_1007_s10654_025_01209_w
Genre Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: Polska Fundacja Gastroenterologii (PL)
– fundername: ZonMw
  grantid: 120720012
  funderid: http://dx.doi.org/10.13039/501100001826
– fundername: Swedish Cancer Foundation
  grantid: 2010/345; CAN 2013/553
  funderid: http://dx.doi.org/10.13039/100012538
– fundername: Narodowe Centrum Badań i Rozwoju
  grantid: N R13 0024 04
  funderid: http://dx.doi.org/10.13039/501100005632
– fundername: Medical Center for Postgraduate Education, Poland
  grantid: 501-1-09-12-12/22
– fundername: Regionala Forskningsrådet Uppsala/Örebro
  grantid: 2368/10-221
  funderid: http://dx.doi.org/10.13039/100019032
– fundername: AFA Försäkring
  grantid: 130072
  funderid: http://dx.doi.org/10.13039/501100002706
– fundername: Kreftforeningen
  funderid: http://dx.doi.org/10.13039/100008730
– fundername: The Dutch Ministry of Health and Health Care Prevention (NL)
  grantid: ZonMw 2008
– fundername: Helse Sør-Øst RHF
  grantid: 5135
  funderid: http://dx.doi.org/10.13039/501100006095
– fundername: Norges Forskningsråd
  grantid: 197309
– fundername: Regionala Forskningsrådet Uppsala/Örebro
  grantid: 2368/10-221
– fundername: Swedish Cancer Foundation
  grantid: 2010/345
– fundername: Helse Sør-Øst RHF
  grantid: 5135
– fundername: Narodowe Centrum Badań i Rozwoju
  grantid: N R13 0024 04
– fundername: Polish-Norwegian Research Programme
  grantid: Pol-Nor/204233/30/2013
– fundername: Swedish Cancer Foundation
  grantid: CAN 2013/553
– fundername: ZonMw
  grantid: 120720012
GroupedDBID ---
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8C1
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AACGO
AAHNG
AAIAL
AAJBT
AAJKR
AANCE
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBHK
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPLY
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTLG
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ABXSQ
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHIC
ACHSB
ACHXU
ACIHN
ACKNC
ACMDZ
ACMFV
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADQXQ
ADRFC
ADTPH
ADULT
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUPB
AEUYN
AEVLU
AEXYK
AEXZC
AFBBN
AFDZB
AFEXP
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
AQUVI
AQVQM
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DCCCD
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HGD
HMCUK
HMJXF
HQ3
HQYDN
HRMNR
HTVGU
HVGLF
HZ~
I09
I5X
IHE
IJ-
IKXTQ
IMOTQ
IPSME
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JAAYA
JBMMH
JBSCW
JCJTX
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JZLTJ
KDC
KOV
KOW
KPH
LAK
LAS
LLZTM
M0T
M1P
M2O
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PHGZM
PHGZT
PMFND
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SA0
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
YLTOR
Z45
ZMTXR
ZOVNA
ZXP
~EX
AAYXX
ABFSG
ABRTQ
ACSTC
AEZWR
AFFHD
AFHIU
AHWEU
AIXLP
CITATION
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
ESTFP
NPM
7QL
7T2
7TK
7TS
7U7
7U9
C1K
H94
K9.
7X8
ADTPV
AOWAS
ID FETCH-LOGICAL-c416t-262e2438a3badc4b1570aaa4b8fb0887490133698d1b3e578137317c9d1b2d943
IEDL.DBID RSV
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001475719700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0393-2990
1573-7284
IngestDate Tue Nov 25 03:32:09 EST 2025
Fri Sep 05 17:24:56 EDT 2025
Tue Dec 02 16:00:27 EST 2025
Thu Oct 09 05:22:36 EDT 2025
Sat Nov 29 07:46:20 EST 2025
Tue Nov 18 22:12:49 EST 2025
Sun Jun 08 01:10:15 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Instrumental variable
Screening
Per-protocol
Colonoscopy
Colorectal cancer
Language English
License 2025. Springer Nature B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c416t-262e2438a3badc4b1570aaa4b8fb0887490133698d1b3e578137317c9d1b2d943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4234-7999
PMID 40278966
PQID 3216580311
PQPubID 33638
PageCount 7
ParticipantIDs swepub_primary_oai_swepub_ki_se_1024530
proquest_miscellaneous_3194656128
proquest_journals_3216580311
pubmed_primary_40278966
crossref_primary_10_1007_s10654_025_01209_w
crossref_citationtrail_10_1007_s10654_025_01209_w
springer_journals_10_1007_s10654_025_01209_w
PublicationCentury 2000
PublicationDate 2025-04-01
PublicationDateYYYYMMDD 2025-04-01
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationTitle European journal of epidemiology
PublicationTitleAbbrev Eur J Epidemiol
PublicationTitleAlternate Eur J Epidemiol
PublicationYear 2025
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References M Bretthauer (1209_CR1) 2022; 387
MA Hernán (1209_CR3) 2017; 377
JG Young (1209_CR8) 2020; 39
Ø Holme (1209_CR10) 2014; 312
N Segnan (1209_CR13) 2011; 103
RE Schoen (1209_CR12) 2012; 366
MA Hernán (1209_CR4) 2006; 17
MA Hernán (1209_CR15) 2021
M Bretthauer (1209_CR6) 2016; 176
M Løberg (1209_CR7) 2016; 27
SA Swanson (1209_CR9) 2015; 16
MF Kaminski (1209_CR5) 2012; 44
JA Hanley (1209_CR2) 2023; 388
WS Atkin (1209_CR11) 2010; 375
L Wang (1209_CR14) 2018; 80
References_xml – volume: 366
  start-page: 2345
  year: 2012
  ident: 1209_CR12
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1114635
– volume: 377
  start-page: 1391
  year: 2017
  ident: 1209_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsm1605385
– volume: 27
  start-page: 393
  year: 2016
  ident: 1209_CR7
  publication-title: Epidemiology
  doi: 10.1097/EDE.0000000000000469
– volume: 39
  start-page: 1199
  year: 2020
  ident: 1209_CR8
  publication-title: Stat Med
  doi: 10.1002/sim.8471
– volume: 80
  start-page: 531
  year: 2018
  ident: 1209_CR14
  publication-title: J R Stat Soc Series B Stat Methodol
  doi: 10.1111/rssb.12262
– volume: 387
  start-page: 1547
  year: 2022
  ident: 1209_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2208375
– volume: 44
  start-page: 695
  year: 2012
  ident: 1209_CR5
  publication-title: Endoscopy
  doi: 10.1055/s-0032-1306895
– volume: 312
  start-page: 606
  year: 2014
  ident: 1209_CR10
  publication-title: JAMA
  doi: 10.1001/jama.2014.8266
– volume: 103
  start-page: 1310
  year: 2011
  ident: 1209_CR13
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djr284
– volume: 176
  start-page: 894
  year: 2016
  ident: 1209_CR6
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2016.0960
– volume: 388
  start-page: 376
  year: 2023
  ident: 1209_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc2215192
– volume: 17
  start-page: 360
  year: 2006
  ident: 1209_CR4
  publication-title: Epidemiology
  doi: 10.1097/01.ede.0000222409.00878.37
– volume: 16
  start-page: 541
  year: 2015
  ident: 1209_CR9
  publication-title: Trials
  doi: 10.1186/s13063-015-1056-8
– volume: 375
  start-page: 1624
  year: 2010
  ident: 1209_CR11
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60551-X
– volume-title: Causal Inference: What If
  year: 2021
  ident: 1209_CR15
SSID ssj0008095
Score 2.4445612
Snippet Background We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale...
We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial....
BackgroundWe recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale...
SourceID swepub
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 419
SubjectTerms Aged
Cancer
Cardiology
Clinical outcomes
Clinical trials
Colonoscopy
Colonoscopy - statistics & numerical data
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - mortality
Colorectal Neoplasms - prevention & control
Confidence intervals
Disease prevention
Early Detection of Cancer - methods
Epidemiology
Estimates
Female
Health risks
Humans
Incidence
Infectious Diseases
Male
Mass Screening - methods
Medical screening
Medicine
Medicine & Public Health
Middle Aged
Mortality
Oncology
Public Health
Risk
Risk Factors
Screening
Title Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects
URI https://link.springer.com/article/10.1007/s10654-025-01209-w
https://www.ncbi.nlm.nih.gov/pubmed/40278966
https://www.proquest.com/docview/3216580311
https://www.proquest.com/docview/3194656128
http://kipublications.ki.se/Default.aspx?queryparsed=id:161554427
Volume 40
WOSCitedRecordID wos001475719700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: Springer Online Journals
  customDbUrl:
  eissn: 1573-7284
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0008095
  issn: 0393-2990
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFD7YKiKIl6p1tJYIgg8amFxmN-ObiMUXi3hj34bcFkplpuz2gj_Bf-05SWZaLxT0bWc3czJkTk6-7Mn3HYBn0pplE4LlsRWS61hr7lpjeWh8I2bGOa9tKjYx3983i0X7oZDC1uNp9zElmSL1BbLbrNGcyq8mwic_24CruNwZmo4fP32d4q-pU60VIp1yCraFKvN3G78uR39gzAv50d-0RNP6s3f7_578DtwqeJO9zg5yF67Efguuvy8Z9S24mf-3Y5mOdA9-ZDljNiwZ6Vn3A9FWvjMMLrjhxU7Z0DM6jr4eW1DExA48ec-K2T6wRI-JgQVCl6_YQdKozTUE2CluzYmsxUjcI7MmydBRXHFSjBjQIitHTO7Dl723n9-846VcA_eI6o65nMkotTJWORu8dqKZ19Za7czSUSzTCD2UmrUmCKciRgqh5ohefIvXMrRaPYDNfujjQ2BRSROaxluL8ENZYzziVmc1iY352tsKxPjWOl-0zKmkxrfuXIWZxrzDMe_SmHdnFbyY7jnKSh6Xtt4ZnaErs3rdKSkQsGEYFBU8nX7G-UhJFtvH4QTbiJYk6HDZr2A7O9HUnaY0L-4vK3g5Osq58cue5Xn2vMkQaYKXrw7xU8Q7pW5U_ejfDD-GGzJ5JR1E2oFN9Ib4BK750-OD9WoXNuYLs5vm1k8QDx5a
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB60igripVUbrbqC4IMuZC85Z-ObiKViexCt0rewtwOlkpRzaos_of_amc0mrRcK-pbLZjZsZmdnM_N9A_BcWjOvQrA81kJyHUvNXW0sD5WvxMQ457VNxSams5nZ26s_ZlDYcsh2H0KSyVKfA7tNKs2p_GoCfPKTy3BF44pFiXyfPn8d7a8pU60VAp1yMrYZKvN3Gb8uR3_4mOfio79xiab1Z_P2_735HbiV_U32pleQu3AptqtwbSdH1FfhZv_fjvVwpDU47emMWTdnxGfddgRb-cHQuOCGFztlXcsoHX05tCCLiR140p4Fs21gCR4TAwvkXb5m-4mjtq8hwI5xa05gLUbkHj1qkgQdxgUnxogOJbKcYnIPvmy-2327xXO5Bu7RqzviciKj1MpY5Wzw2olqWlprtTNzR7ZMo-uh1KQ2QTgV0VIINUXvxdd4LkOt1X1Yabs2rgOLSppQVd5adD-UNcaj3-qsJrIxX3pbgBi-WuMzlzmV1PjWnLEw05g3OOZNGvPmpICX4zOHPZPHha03BmVo8qxeNkoKdNjQDIoCno23cT5SkMW2sfuObURNFHS47BfwoFeisTtNYV7cXxbwalCUM-EXvcuLXvNGQcQJni8d4FHEJ6WuVPnw3wQ_hetbuzvbzfb72YdHcEMmDaWkpA1YQc2Ij-GqPz7aXy6epBn2E8NvIFY
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD6CgSYkNGDcMgYYCYkHZi2xndbhDQEVCKgmcdHeIt8qTaCkassmfsL-9c6xk6xcNAnxlqbOSeoeH3_O8fcdgKfC6FnpveGhKgRXIVfcVtpwX7qyGGlrnTKx2MR4OtWHh9XBGos_7nbvU5KJ00AqTc1qf-5n-2vEt1GpOJVijeRPfnIZrigqGkTr9U9fh1is81h3hQionAJvR5v5u41fp6Y_8OZarvQ3XdE4F01u_P-vuAlbHQ5lL5Pj3IJLodmGzY9dpn0brqf3eSzRlG7DaZI5Zu2Mkc510xKd5SfDoIMLYXwA1jaMtqkv-xYUSfEGjrxqwUzjWaTNBM88oc4X7Chq16baAuwYl-xE4mIk-pHYlGRoHhaclCRatMi6rSd34MvkzedXb3lXxoE7RHsrLkYiCCW1kdZ4p2xRjnNjjLJ6ZinGKYQkUo4q7QsrA0aQQo4R1bgKPwtfKXkXNpq2CfeBBSm0L0tnDMISabR2iGetUSRC5nJnMij6f7B2ncY5ldr4Xp-rM1Of19jndezz-iSD58M186TwcWHr3d4x6m60L2spCgRyGB6LDJ4MX-M4peSLaUL7A9sUFUnTIRzI4F5yqOF2itK_uO7MYK93mnPjFz3Ls-SFgyHSCu9OfcOjgFcKVcp8598MP4bNg9eT-sO76fsHcE1EB6W9SruwgY4RHsJVd7w6Wi4excF2Bq4QKTo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+colonoscopy+screening+on+risks+of+colorectal+cancer+and+related+death%3A+instrumental+variable+estimation+of+per-protocol+effects&rft.jtitle=European+journal+of+epidemiology&rft.au=Shi%2C+Joy&rft.au=L%C3%B8berg%2C+Magnus&rft.au=Kalager%2C+Mette&rft.au=Wieszczy%2C+Paulina&rft.date=2025-04-01&rft.issn=0393-2990&rft.eissn=1573-7284&rft.volume=40&rft.issue=4&rft.spage=419&rft.epage=425&rft_id=info:doi/10.1007%2Fs10654-025-01209-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10654_025_01209_w
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0393-2990&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0393-2990&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0393-2990&client=summon